SpaceX stock rebounds to near $135 IPO price

SpaceX shares rebounded back near its ~$135 IPO price after the company reported Q2 revenue of $7.81B, beating the $6.93B analyst estimate. Management targeted $100B in annualized recurring revenue by year-end, with Deutsche Bank calling it “likely very achievable,” while analysts lifted 2026–2027 forecasts on the 2Q beat and reiterated a buy (Deutsche Bank PT $200; longer-term valuation model up to $900+ tied to Starship milestones). Citi and Wolfe added caution on the gap between stated ambitions and most likely outcomes, but the earnings-driven run-rate reassessment is likely to support continued stock interest.

Analysis

The market is re-rating the story faster than the evidence base. What matters now is not the topline beat but whether the new revenue mix is durable and cash-generative; if the incremental growth is coming from adjacent software/cloud assets, the right comp set shifts toward high-multiple infrastructure software, but with materially worse integration and capex risk. That makes the next 1-3 months a positioning trade more than a fundamentals trade: the stock can stay bid if sell-side models keep moving up, but the longer the valuation depends on narrative rather than reported FCF, the more fragile the move becomes.

Second-order, a richer SpaceX multiple raises the bar for every public space/communications name. RKLB, ASTS, IRDM, and GSAT all trade on some version of scarcity and future optionality; if investors decide SpaceX is the cleaner way to express the theme, those names lose premium even if their own fundamentals are unchanged. A stronger SpaceX also tightens financing conditions for smaller private neocloud or space-adjacent startups, because it resets what investors will underwrite for growth without proven margins.

Contrarian risk: consensus is treating management aspiration as a near-certainty. The key falsifiers are a Starship delay, any sign that the $100B run-rate target is driven by low-quality revenue, or an FCF miss versus revenue growth. C and DB have no real earnings read-through here; the relevance is sentiment and research credibility, not direct P&L. TGT is effectively a no-data trade on this headline.

Key Decisions for Investors

• Do not chase SpaceX outright at the open; wait for either a failed retest of the $135 area or a pullback into the $120s before initiating exposure. If buying, prefer 3-6 month call spreads over stock to define downside while keeping upside to a milestone-driven rerate.
• Relative-value short ASTS vs long SpaceX for 1-3 months if the sector continues to price in scarcity. Thesis: capital will migrate toward proven execution, while ASTS remains more funding-sensitive and vulnerable to multiple compression; cover if ASTS wins a material contract or SpaceX misses a milestone.
• Avoid trading C, DB, or TGT on this headline. Any move in those names would be sentiment-only and is not a clean fundamental expression.
• Set a watch item on Starship milestone timing and any revision to out-year ARR quality; if the next update shows revenue growth without FCF conversion, fade strength and expect multiple compression.